IBDEI34U ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50029,2)
 ;;=^5009055
 ;;^UTILITY(U,$J,358.3,50030,0)
 ;;=L03.322^^193^2487^15
 ;;^UTILITY(U,$J,358.3,50030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50030,1,3,0)
 ;;=3^Acute Lymphangitis of Back
 ;;^UTILITY(U,$J,358.3,50030,1,4,0)
 ;;=4^L03.322
 ;;^UTILITY(U,$J,358.3,50030,2)
 ;;=^5009056
 ;;^UTILITY(U,$J,358.3,50031,0)
 ;;=L03.323^^193^2487^16
 ;;^UTILITY(U,$J,358.3,50031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50031,1,3,0)
 ;;=3^Acute Lymphangitis of Chest Wall
 ;;^UTILITY(U,$J,358.3,50031,1,4,0)
 ;;=4^L03.323
 ;;^UTILITY(U,$J,358.3,50031,2)
 ;;=^5009057
 ;;^UTILITY(U,$J,358.3,50032,0)
 ;;=L03.324^^193^2487^18
 ;;^UTILITY(U,$J,358.3,50032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50032,1,3,0)
 ;;=3^Acute Lymphangitis of Groin
 ;;^UTILITY(U,$J,358.3,50032,1,4,0)
 ;;=4^L03.324
 ;;^UTILITY(U,$J,358.3,50032,2)
 ;;=^5009058
 ;;^UTILITY(U,$J,358.3,50033,0)
 ;;=L03.325^^193^2487^24
 ;;^UTILITY(U,$J,358.3,50033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50033,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,50033,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,50033,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,50034,0)
 ;;=L03.326^^193^2487^30
 ;;^UTILITY(U,$J,358.3,50034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50034,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,50034,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,50034,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,50035,0)
 ;;=L03.329^^193^2487^29
 ;;^UTILITY(U,$J,358.3,50035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50035,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,50035,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,50035,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,50036,0)
 ;;=L08.9^^193^2487^171
 ;;^UTILITY(U,$J,358.3,50036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50036,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,50036,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,50036,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,50037,0)
 ;;=L11.0^^193^2487^10
 ;;^UTILITY(U,$J,358.3,50037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50037,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,50037,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,50037,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,50038,0)
 ;;=L20.0^^193^2487^91
 ;;^UTILITY(U,$J,358.3,50038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50038,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,50038,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,50038,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,50039,0)
 ;;=L20.81^^193^2487^88
 ;;^UTILITY(U,$J,358.3,50039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50039,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,50039,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,50039,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,50040,0)
 ;;=L20.82^^193^2487^153
 ;;^UTILITY(U,$J,358.3,50040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50040,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,50040,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,50040,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,50041,0)
 ;;=L20.84^^193^2487^165
 ;;^UTILITY(U,$J,358.3,50041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50041,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,50041,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,50041,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,50042,0)
 ;;=L20.89^^193^2487^86
